To learn more about how your data is used by us when you use the website, please read our Privacy Policy. We use cookies to deliver our services and to ensure that we give you the best experience on our website. For details on our use of cookies, please go to the Cookie Policy

Turning a new page on antibiotics

For 70 years the world has mismanaged the common good of antibiotics. The result is a growing global burden of antibiotic resistance, threatening to take health care back to an era where ordinary infections might once again become fatal.

At a historic three day conference at Uppsala University, Sweden, 190 delegates representing 45 countries and many leading stake holders – civil society, academia, industry, governments, authorities, supranational organizations – agreed on Wednesday to turn a new page and move towards concerted action on antibiotic resistance.

“This is a starting point for a global compact on antibiotic resistance”, says Professor Otto Cars, chairman of ReAct, the international network for Action on Antibiotic Resistance.

The new signals from the Uppsala meeting include:

• A shared conviction that antibiotic resistance is a universal problem. Like global warming, it requires joint action, not least by governmental alliances.

• A clear signal from the pharmaceutical industry that return of investment on research and development of new antibiotics and diagnostic tools will have to be de-linked from market sales in order to boost necessary innovation while yet limiting the use of antibiotics. This requires a new business model where private and public sectors cooperate.

• A strong recommendation to all stakeholders to speed up the efforts to limit unnecessary use of antibiotics, while at the same time making the medicines affordable and accessible in developing countries.

• A commitment to improve the monitoring of antibiotic resistance across the world, through shared data and increased efforts. A global network of surveillance will require common methods, and is crucial for both prudent use and needs driven development of new agents.

The year 2011 marks a new beginning. ReAct is pleased to note that the World Health Day will be devoted to antimicrobial resistance. Other initiatives across the world next year include:

• A final report from TATFAR, The Transatlantic Task Force on Antibiotic Resistance.

• A policy meeting on antibiotic resistance in Delhi, India.

• A WHO Action Plan on Antibiotic Resistance.

• A number of regional initiatives, including in Southeast Asia, Africa and The Middle East.

A more detailed report on meeting outcomes will be made available shortly on www.reactgroup.org.

For more information or inquiries of interviews, please contact Peter Lundström of ReAct at +46 (0) 70-937 15 35, or Peter.Lundstrom@medsci.uu.se

Relaterat / Nyheter

The growing problem of antibiotic resistance, which compromises our ability to treat common infections, represents one of the greatest threats to public health worldwide. Researchers, politicians and representatives from public health organisations and the pharmaceutical industry will gather in Uppsala from 6–8 September to discuss global strategies.

The Alliance for the Prudent Use of Antibiotics (APUA) is presenting its prestigious leadership award to Prof. Otto Cars, founding Director of ReAct, for his “outstanding leadership in the worldwide effort to contain antibiotic resistance”.